Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review

Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review

Purpose Polygenic risk influences susceptibility to cancer. We assessed whether polygenic risk scores could be used in conjunction with other predictors of future disease status in cost-effective risk-stratified screening for cancer. Methods We undertook a systematic review of papers that evaluated...

Full description

Bibliographic Details
Main Authors:	Dixon, P, Keeney, E, Taylor, J, Wordsworth, S, Martin, R
Format:	Journal article
Language:	English
Published:	Elsevier 2022

Similar Items

Polygenic risk scores for prediction of breast cancer and breast cancer subtypes
by: Mavaddat, N, et al.
Published: (2018)

Polygenic risk scores for prediction of breast cancer risk in Asian populations
by: Ho, W-K, et al.
Published: (2021)

Polygenic inheritance, GWAS, polygenic risk scores, and the search for functional variants
by: Crouch, DJM, et al.
Published: (2020)

Genome editing, Goldilocks and polygenic risk scores
by: Gyngell, C, et al.
Published: (2019)

Association between polygenic risk score and risk of myopia
by: Ghorbani Mojarrad, N, et al.
Published: (2019)

Editorial on polygenic risk scores - colloquium held at the Centre for Personalised Medicine, Oxford
by: Dixon, P, et al.
Published: (2023)

Contribution of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP) to the ongoing debate on the value of prostate cancer screening
by: Martin, RM, et al.
Published: (2022)

Polygenic risk and hazard scores for Alzheimer's disease prediction
by: Leonenko, G, et al.
Published: (2019)

Development of a polygenic risk score to improve screening for fracture risk: a genetic risk prediction study.
by: Forgetta, V, et al.
Published: (2020)

Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer
by: Karunamuni, RA, et al.
Published: (2021)

Polygenic hazard score for prostate cancer risk stratification: validation in additional longitudinal cohorts
by: Tye, K, et al.
Published: (2019)

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts.
by: Seibert, TM, et al.
Published: (2018)

Associations of polygenic risk scores with risks of stroke and its subtypes in Chinese
by: Yang, S, et al.
Published: (2023)

Polygenic risk scores for complex diseases: where are we now?
by: Loh, Marie, et al.
Published: (2023)

Polygenic risk score for embryo selection—not ready for prime time
by: Polyakov, A, et al.
Published: (2022)

Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
by: Huynh-Le, M, et al.
Published: (2021)

Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry
by: Darst, BF, et al.
Published: (2023)

Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score
by: Huynh-Le, M, et al.
Published: (2022)

Private Random Variate Sampling for Secure and Federated Polygenic Risk Scores
by: Yen, Derek Jia-Wen
Published: (2024)

Assessing agreement between different polygenic risk scores in the UK Biobank
by: Clifton, LEI, et al.
Published: (2022)

Three models for the regulation of polygenic scores in reproduction
by: Munday, S, et al.
Published: (2021)

Monogenic, multigenic, and polygenic determinants of cancer risk
by: Banava, Helen.
Published: (2005)

Improved prediction of fracture risk leveraging a genome-wide polygenic risk score
by: Lu, T, et al.
Published: (2021)

Improved prediction of fracture risk leveraging a genome-wide polygenic risk score
by: Lu, T, et al.
Published: (2021)

Significant Sparse Polygenic Risk Scores across 813 traits in UK Biobank
by: Tanigawa, Yosuke, et al.
Published: (2022)

Hypertension, a dementia polygenic risk score, APOE genotype and incident dementia
by: Littlejohns, T, et al.
Published: (2022)

Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders
by: Calafato, MS, et al.
Published: (2018)

African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer
by: Karunamuni, RA, et al.
Published: (2020)

Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration
by: Tan, Chin Hong, et al.
Published: (2020)

Integrating genome-wide polygenic risk scores and non-genetic risk to predict colorectal cancer diagnosis using UK Biobank data: population based cohort study
by: Briggs, SEW, et al.
Published: (2022)

Calculating polygenic risk scores (PRS) in UK Biobank: A practical guide for epidemiologists
by: Collister, JA, et al.
Published: (2022)

Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations
by: Dai, J, et al.
Published: (2019)

Global Biobank analyses provide lessons for developing polygenic risk scores across diverse cohorts
by: Wang, Y, et al.
Published: (2023)

Incorporating polygenic risk into the Leicester Risk Assessment score for 10-year risk prediction of type 2 diabetes
by: Liu, X, et al.
Published: (2024)

Using polygenic scores in social science research: Unraveling childlessness
by: Verweij, RM, et al.
Published: (2019)

Polygenic susceptibility in rheumatoid arthritis.
by: Wordsworth, B, et al.
Published: (1991)

Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
by: Khera, Amit V., et al.
Published: (2020)

Polygenic risk scores for pan-cancer risk prediction in the Chinese population: A population-based cohort study based on the China Kadoorie Biobank
by: Zhu, M, et al.
Published: (2025)

Genome-wide polygenic risk score, cardiometabolic risk factors, and type 2 diabetes mellitus in the Chinese population
by: Huang, N, et al.
Published: (2023)

Common variants at 30 loci contribute to polygenic dyslipidemia.
by: Kathiresan, S, et al.
Published: (2009)